Diana Miao

14.4k total citations · 2 hit papers
23 papers, 1.7k citations indexed

About

Diana Miao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Diana Miao has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Diana Miao's work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (5 papers). Diana Miao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (5 papers). Diana Miao collaborates with scholars based in United States, Australia and Germany. Diana Miao's co-authors include Eliezer M. Van Allen, Kwok‐Kin Wong, Dennis O. Adeegbe, David E. Root, Jennifer A. Lo, Kathleen B. Yates, Kevin Bi, Flavian D. Brown, Sarah A. Weiss and Robert T. Manguso and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Immunity.

In The Last Decade

Diana Miao

21 papers receiving 1.7k citations

Hit Papers

In vivo CRISPR screening identifies Ptpn2 as a cancer imm... 2017 2026 2020 2023 2017 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Miao United States 12 952 769 715 328 254 23 1.7k
Kim C. Ohaegbulam United States 14 1.2k 1.3× 416 0.5× 884 1.2× 339 1.0× 180 0.7× 19 1.8k
Italia Grenga United States 20 1.1k 1.2× 326 0.4× 617 0.9× 337 1.0× 123 0.5× 43 1.6k
Alex Chehrazi‐Raffle United States 11 869 0.9× 374 0.5× 461 0.6× 331 1.0× 171 0.7× 64 1.3k
Hong Zheng China 13 569 0.6× 632 0.8× 505 0.7× 118 0.4× 179 0.7× 67 1.4k
Vittore Cereda Italy 18 859 0.9× 352 0.5× 733 1.0× 305 0.9× 98 0.4× 30 1.3k
Si-Pei Wu China 13 941 1.0× 544 0.7× 300 0.4× 659 2.0× 386 1.5× 23 1.5k
Valeria Cancila Italy 17 402 0.4× 526 0.7× 395 0.6× 151 0.5× 243 1.0× 49 1.3k
Falguni Parikh India 13 747 0.8× 474 0.6× 425 0.6× 155 0.5× 327 1.3× 50 1.3k
Tzeela Cohen United States 16 456 0.5× 619 0.8× 432 0.6× 231 0.7× 153 0.6× 24 1.3k

Countries citing papers authored by Diana Miao

Since Specialization
Citations

This map shows the geographic impact of Diana Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Miao more than expected).

Fields of papers citing papers by Diana Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Miao. The network helps show where Diana Miao may publish in the future.

Co-authorship network of co-authors of Diana Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Miao. A scholar is included among the top collaborators of Diana Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Miao. Diana Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Miao, Diana, Ursula A. Matulonis, & Rebecca L. Porter. (2025). Ovarian Cancer Therapy. Cold Spring Harbor Perspectives in Medicine. 16(3). a038232–a038232.
3.
Smith, Anna Jo Bodurtha, et al.. (2020). Minimally Invasive Radical Hysterectomy for Cervical Cancer: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology. 28(3). 544–555.e7. 16 indexed citations
4.
Miao, Diana & Amanda N. Fader. (2020). Surgical Clinical Trials in Gynecology: Rare, Challenging but Desperately Needed. Journal of Minimally Invasive Gynecology. 28(3). 379–383. 1 indexed citations
6.
Smart, Alicia, Claire A. Margolis, Harold Pimentel, et al.. (2018). Intron retention is a source of neoepitopes in cancer. Nature Biotechnology. 36(11). 1056–1058. 194 indexed citations
7.
Vokes, Natalie I., Diana Miao, Claire A. Margolis, et al.. (2018). Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 3036–3036. 6 indexed citations
8.
Voss, Martin H., Jacqueline L. Buros, Matthew D. Hellmann, et al.. (2018). Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC).. Journal of Clinical Oncology. 36(15_suppl). 4518–4518. 19 indexed citations
9.
Miao, Diana, Claire A. Margolis, Dylan J. Martini, et al.. (2017). Loss-of-function of PBRM1 to predict response to anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 35(15_suppl). 3016–3016. 3 indexed citations
10.
Miao, Diana, Guillermo de Velasco, Dennis O. Adeegbe, et al.. (2017). Abstract A18: Genomic and neoantigen evolution and resistance to immune checkpoint blockade in metastatic renal cell carcinoma. Cancer Immunology Research. 5(3_Supplement). A18–A18. 1 indexed citations
11.
George, Suzanne, Diana Miao, George D. Demetri, et al.. (2017). Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma. Immunity. 46(2). 197–204. 361 indexed citations breakdown →
12.
Manguso, Robert T., Hans W. Pope, Margaret D. Zimmer, et al.. (2017). In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 547(7664). 413–418. 774 indexed citations breakdown →
13.
Mouw, Kent W., James M. Cleary, Brendan Reardon, et al.. (2016). Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma. Clinical Cancer Research. 23(12). 3214–3222. 36 indexed citations
14.
Nathanson, Tavi, Arun Ahuja, Alex Rubinsteyn, et al.. (2016). Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. Cancer Immunology Research. 5(1). 84–91. 122 indexed citations
15.
Miao, Diana & Eliezer M. Van Allen. (2016). Genomic determinants of cancer immunotherapy. Current Opinion in Immunology. 41. 32–38. 23 indexed citations
16.
Velasco, Guillermo de, Diana Miao, Martin H. Voss, et al.. (2016). Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer Immunology Research. 4(10). 820–822. 51 indexed citations
17.
Liu, David, Philip H. Abbosh, Diana Miao, et al.. (2016). Genomic evolution in muscle-invasive bladder cancer resistant to neoadjuvant chemotherapy.. Journal of Clinical Oncology. 34(15_suppl). 4518–4518. 1 indexed citations
18.
Makhni, Melvin C., Diana Miao, David Zurakowski, & Charles S. Day. (2014). Are academic orthopedic surgeons interested in global health?. PubMed. 43(3). E37–42. 3 indexed citations
19.
Kuo, Phoebe, Tristan L. Hartzell, Kyle R. Eberlin, et al.. (2014). The Characteristics of Referring Facilities and Transferred Hand Surgery Patients. Journal of Bone and Joint Surgery. 96(6). e48–e48. 15 indexed citations
20.
Miao, Diana, Sera L. Young, & Christopher D. Golden. (2014). A meta‐analysis of pica and micronutrient status. American Journal of Human Biology. 27(1). 84–93. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026